RT info:eu-repo/semantics/article
T1 Prevalence and Predictors of Long Covid in a Cohort of Brazilian Adults 12 Months After Acute Infection: A Cross‐Sectional Study
A1 Covre, Eduardo Rocha
A1 Laranjeira, Carlos
A1 Carreira, Lígia
A1 Höring, Carla Franciele
A1 Góes, Herbert Leopoldo de Freitas
A1 Baldissera, Vanessa Denardi Antoniassi
A1 Marques, Priscila Garcia
A1 Meireles, Viviani Camboin
A1 Tostes, Maria Fernanda do Prado
A1 Oliveira, Rosana Rosseto de
A1 Paiano, Marcelle
A1 Ageno, Rosella Santoro
A1 Moroskoski, Márcia
A1 Puente Alcaraz, Jesús
A1 Vissoci, João Ricardo Nickenig
A1 Facchini, Luiz Augusto
A1 Salci, Maria Aparecida
K1 Adults
K1 Brazil
K1 COVID-19
K1 Long Covid
K1 Predictors
K1 Prevalence
K1 Covid-19
K1 COVID-19 (Disease)
K1 Salud pública
K1 Public health
AB Introduction: Since the onset of the pandemic in early 2020, various reports have emerged regarding persistent symptomsassociated with Covid‐19. Nevertheless, there is insufficient data on the persistence of symptoms over time. This study sought toestimate the prevalence of persistent symptoms 12 months after Covid‐19 infection and identify predictors of long Covid inadults living in the State of Paraná, southern Brazil, according to the level of severity of Covid‐19 infection.Method: An observational and cross‐sectional survey was conducted with Brazilian adults diagnosed with Covid‐19, as assessedfrom data available in two official Covid‐19 notification databases in Brazil, using telephone interviews. Descriptive statistics,tests of associations and simple and multiple binary logistic regression analysis were used to identify predictors of long Covid.Results: In total, 1033 adults participated in the study. The overall prevalence of long Covid was 60.3% (n = 623). Prevalencewas higher in women (67.7%), people aged between 50 and 59 years (65.8%) and in individuals who received treatment in anIntensive Care Unit (ICU) during the acute phase of Covid‐19 infection (74.4%, n = 241). The risk factors associated with agreater chance of developing long Covid were: female (OR 2.38; 95% CI 1.55; 3.66), living in the Brazilian northwest healthmacro‐region (OR 2.20; 95% CI 1.21; 4.00), presenting multimorbidity (OR 1.86; 95% CI 1.06; 3.28), having an average of sixsymptoms in the acute phase of Covid‐19 (OR 1.22; 95% CI 1.17; 1.28) and having received treatment in an ICU (OR 4.86; 95%CI 2.83; 8.35) and inpatient ward (OR 2.45; 95% CI 1.47; 4.09)
PB Wiley
SN 1369-6513
YR 2025
FD 2025-11
LK https://hdl.handle.net/10259/11363
UL https://hdl.handle.net/10259/11363
LA eng
NO This study was funded by Ministério da Ciência, Tecnologia, Inovações e Comunicações (FNDCT/MCTIC), Ministério da Saúde (MS) and ConselhoNacional de Desenvolvimento Científico e Tecnológico (CNPq)—Processo n◦ 402882/2020‐2. It was also supported by FCT—Fundação para a Ciência e aTecnologia, I.P. (UID/05704/2023) and by the Scientific Employment Stimulus—Institutional Call—[https://doi.org/10.54499/CEECINST/00051/2018/CP1566/CT0012, accessed on 20 September 2025]
DS Repositorio Institucional de la Universidad de Burgos
RD 29-abr-2026